- Increased Neurofilament Light Chain Is Associated with Increased Risk of Long-Term Mortality in Cerebral Small Vessel Disease
-
Jacob MA, Peters N, Cai M, Duering M, Engelter ST, Kuhle J, de Leeuw FE, Tuladhar AM
- KMID: 2530533
- J Stroke.
- 2022 May;24(2):296-299.
- doi: 10.5853/jos.2021.04385
-
- CITED
-
- Close
- SHARE
-
- Close
- Serum Neurofilament Light Chain Levels Are Related to Small Vessel Disease Burden
-
Duering M, Konieczny , Tiedt S, Baykara E, Tuladhar A, van Leijsen E, Lyrer P, Engelter S, Gesierich , Achmüller M, Barro C, Adam R, Ewers M, Dichgans M, Kuhle J, de Leeuw F, Peters N
- KMID: 2424426
- J Stroke.
- 2018 May;20(2):228-238.
- doi: 10.5853/jos.2017.02565
BACKGROUND AND PURPOSE: Neurofilament light chain (NfL) is a blood marker for neuroaxonal damage. We assessed the association between serum NfL and cerebral small vessel disease (SVD), which is highly... -
- CITED
-
- Close
- SHARE
-
- Close
- Serum Neurofilament Light Chain Is Associated with Incident Lacunes in Progressive Cerebral Small Vessel Disease
-
Peters N, van Leijsen E, Tuladhar AM, Barro C, Konieczny MJ, Ewers M, Lyrer P, Engelter ST, Kuhle J, Duering M, de Leeuw FE
- KMID: 2508040
- J Stroke.
- 2020 Sep;22(3):369-376.
- doi: 10.5853/jos.2019.02845
Background and Purpose Serum neurofilament light (NfL)-chain is a circulating marker for neuroaxonal injury and is also associated with severity of cerebral small vessel disease (SVD) cross-sectionally. Here we explored... -
- CITED
-
- Close
- SHARE
-
- Close
- Simplified Assessment of Lesion Water Uptake for Identification of Patients within 4.5 Hours of Stroke Onset: An Analysis of the MissPerfeCT Study
-
Sporns PB, Höhne M, Meyer L, Krogias C, Puetz V, Thierfelder KM, Duering M, Kaiser D, Langner S, Brehm A, Rotkopf LT, Kunz WG, Fiehler J, Heindel W, Schramm P, Wiendl H, Minnerup H, Psychogios MN, Kemmling A, Minnerup J
- KMID: 2534268
- J Stroke.
- 2022 Sep;24(3):390-395.
- doi: 10.5853/jos.2022.00220
Background and Purpose Many patients with stroke cannot receive intravenous thrombolysis because the time of symptom onset is unknown. We tested whether a simple method of computed tomography (CT)-based quantification... -
- CITED
-
- Close
- SHARE
-
- Close
